Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders

NCT03261050 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03261050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03261050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
July 10, 2017
Completion date
January 31, 2025
Enrollment
83 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

eating disorder